Cite

    Trevanne Matthews Hew and Lara Zuberi. “PARP Inhibitor Olaparib Use in a BRCA1-Positive Patient With Metastatic Triple-Negative Breast Cancer, Without the Initial Use of Platinum-Based Chemotherapy, Showing Significant Rapid Near Resolution of Large Liver Metastasis While Patient Experienced Gout-Like Symptoms.” Journal of investigative medicine high impact case reports, vol. 7, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100095161087.0x0000c0